3/25/2024 | 293430900000 | ACTIVE SUBSTANCE CONTAINED IN THE MEDICINAL PRODUCT COMPOSITION (CHLORPROMAZINE HCL) | XXXXXXXXXX | 725 | KILOGRAM | 203922 | FRANCE | NA |
3/8/2024 | 293942000012 | PSEUDOEPHEDRINE HYDR-OCHLORIDE EUROPEAN | XXXXXXXXXX | 3 | UNIT | 300 | FRANCE | NA |
11/20/2023 | 293942000012 | PSEUDOEPHEDRINE HYDROCHLORIDE, EUROPEAN | XXXXXXXXXX | 3 | UNIT | 300.02 | FRANCE | NA |
8/10/2023 | 293942000012 | PSEUDOEPHEDRINE HYDROCHLORIDE, EUROPEAN | XXXXXXXXXX | 1 | ADET(UNIT) | 90.4 | FRANCE | NA |
8/1/2023 | 293430900000 | ACTIVE SUBSTANCE FOUND IN THE MEDICINAL PRODUCT COMPOSITION (CHLORPROMAZINE HCL) | XXXXXXXXXX | 538.05 | KİLOGRAM | 153306.68 | FRANCE | NA |
7/20/2023 | 293410000019 | PIOGLITAZONE HCL FOR R&D-ANALYSIS PURPOSES | XXXXXXXXXX | 1 | UNIT | 96.56 | FRANCE | NA |
5/8/2023 | 293499909027 | - ALFUZOSIN HCL EUR. PHARM. IMP. A (NUCLEIC ACIDS AND THEIR SALTS, WITH OR WITHOUT CHEMICALLY DEFINED STRUCTURE); OTHER HETEROCYCLIC COMPOUNDS: ) [SL85.0170-10] | XXXXXXXXXX | 1 | UNIT | 460.02 | FRANCE | NA |
5/8/2023 | 293499909027 | ALFUZOSIN HCL EUR. PHARM. IMP. D (NUCLEIC ACIDS AND THEIR SALTS, WITH OR NOT CHEMICALLY DETERMINED; OTHER HETEROCYCLIC COMPOUNDS) [SL79.0722-10N] | XXXXXXXXXX | 1 | UNIT | 460.02 | FRANCE | NA |
5/8/2023 | 293499909027 | ALFUZOSIN HCL EUR. PHARM. IMP. E (NUCLEIC ACIDS AND THEIR SALTS, OTHER HETEROCYCLIC COMPOUNDS) [SL85.0960-10] | XXXXXXXXXX | 1 | UNIT | 462.54 | FRANCE | NA |
5/2/2023 | 293942000011 | PSEUDOEPHEDRINE HYDROCHLORIDE CRS 100 MG | XXXXXXXXXX | 2 | UNIT | 257.95 | FRANCE | NA |